We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Nuvo Pharmaceuticals reported topline results from its multi-center, randomized, placebo-controlled, double-blind, parallel group trial in patients, with grade I or II ankle sprains and in particular reported that the Trial had failed to meet its primary